Dr. Modhi Gude, MD (he/him) is an Endocrinologist in Oklahoma city, OK with over 17 years of experience. What is your opinion of Dr. Modhi Gude, MD? Rate this provider below so other people can make informed decision.
Over 17 Years of Experience
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Modhi Gude, MD has received over $6,267 which includes payments from the following companies:
$1,568.37 from AstraZeneca Pharmaceuticals LP
$1,143.64 from LILLY USA, LLC
$722.10 from Novo Nordisk Inc
$598.08 from sanofi-aventis U.S. LLC
$438.38 from Boehringer Ingelheim Pharmaceuticals, Inc.
$329.80 from AbbVie, Inc.
$300.00 from Tandem Diabetes Care, Inc.
$237.58 from Amgen Inc.
$162.67 from Shire North American Group Inc
$93.09 from Merck Sharp & Dohme Corporation
$90.58 from Abbott Laboratories
$80.35 from Bayer HealthCare Pharmaceuticals Inc.
$60.16 from Medtronic MiniMed, Inc.
$58.41 from INSULET CORPORATION
$56.29 from Antares Pharma, Inc.
$49.76 from Radius Health, Inc.
$40.45 from Endo Pharmaceuticals Inc.
$33.89 from Takeda Pharmaceuticals America, Inc.
$30.93 from GlaxoSmithKline, LLC.
$26.52 from Corcept Therapeutics
Payments received by Dr. Modhi Gude, MD were from the following categories:
$5,645.74 Food and Beverage
$300.00 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!